人体内源性逆转录病毒K有助于质母细胞瘤中的干细胞利基
Ashish H Shah1, Sarah R Rivas2, Tara T Doucet-O'Hare3
1University of Miami School of Medicine, Department of Neurosurgery, Miami, Florida, USA.
The Journal of clinical investigation
|July 3, 2023
概括
人体内源逆转录病毒 (HERVs),特别是HERV-K (HML-2),在恶性质瘤中被重新激活,导致癌症干和不良结果. 用抗逆转录病毒药物抑制HML-2降低了瘤活力,这表明它是治疗点.
科学领域:
- 基因组学就是基因组学.
- 在瘤学瘤学.
- 病毒学 病毒学
背景情况:
- 人体内源逆转录病毒 (HERVs) 是人类基因组中集成的古老病毒感染的遗留物.
- HERV-K (HML-2),一个最近集成的 HERV,可以在特定的癌症类型中重新激活.
- 恶性质结质瘤的特征是持久的癌症干细胞,导致治疗耐药性和复发.
研究的目的:
- 研究HERV-K (HML-2) 在恶性质瘤中的作用.
- 确定HML-2是否有助于癌症干细胞表型和瘤发生.
- 探索HML-2作为质母细胞瘤的潜在治疗点.
主要方法:
- 单细胞RNA测序 (scRNA-Seq) 用于识别HML-2表达细胞.
- 在质母细胞瘤模型中抑制HML-2表达的CRISPR干扰.
- 对逆转录病毒病毒形成和逆转录酶活性的分析.
- 用抗逆转录病毒药物治疗以评估治疗疗效.
主要成果:
- 在恶性质瘤 (脑脊液和瘤组织) 中发现了HML-2的病理表达,与癌症干细胞表型和预后不佳有关.
- 在驱动质母细胞瘤可塑性的神经前体样细胞中发现了升高的HML-2转录.
- 在实验室和体内,HML-2关键地维持了质母细胞瘤干和瘤发生.
- 通过OCT4激活,HML-2调节了胚胎干细胞程序并改变了细胞形态.
- 抑制HML-2降低了瘤活力,多能性和逆转录酶活性.
结论:
- 在质母细胞瘤干细胞利基中,HML-2发挥着根本性的作用.
- 向HML-2为质母细胞瘤提供了潜在的治疗策略,解决治疗耐药性和复发问题.
相关概念视频
01:51Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
01:26Stem Cell Niche
5.2K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
5.2K
02:40Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K